Wendell David Associates Inc. Has $9.75 Million Stock Position in Danaher Corporation $DHR

Wendell David Associates Inc. reduced its stake in Danaher Corporation (NYSE:DHR) by 5.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,167 shares of the conglomerate’s stock after selling 2,665 shares during the period. Danaher makes up approximately 1.0% of Wendell David Associates Inc.’s holdings, making the stock its 28th largest holding. Wendell David Associates Inc.’s holdings in Danaher were worth $9,748,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of DHR. WFA of San Diego LLC acquired a new position in Danaher during the second quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher in the 2nd quarter valued at $27,000. TruNorth Capital Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth about $28,000. Tripletail Wealth Management LLC acquired a new stake in shares of Danaher during the 3rd quarter worth about $31,000. Finally, Red Tortoise LLC increased its position in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.9%

Shares of DHR opened at $239.99 on Friday. The firm has a market capitalization of $169.52 billion, a price-to-earnings ratio of 49.48, a PEG ratio of 3.68 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The business’s fifty day moving average price is $229.99 and its two-hundred day moving average price is $212.84. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23.

Danaher (NYSE:DHR) last released its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the company posted $1.71 earnings per share. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s payout ratio is currently 26.39%.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Guggenheim boosted their price target on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, January 2nd. Rothschild & Co Redburn reiterated a “neutral” rating and issued a $220.00 target price (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. The Goldman Sachs Group increased their price target on Danaher from $265.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday. JPMorgan Chase & Co. raised their price target on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Finally, Redburn Partners set a $220.00 price objective on Danaher in a research note on Wednesday, October 8th. Twenty research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $252.09.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the transaction, the senior vice president directly owned 2,625 shares in the company, valued at approximately $552,352.50. This represents a 66.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 30,248 shares of company stock worth $6,609,663. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.